NiFe-LDH-enhanced Ru single-atom catalysts anchored on MXenes for synergistic photothermal–nanocatalytic cancer therapy
Sharipova GulniholBukhara State Medical Institute Named After Abu Ali Ibn Sino, 1 Navoi Street, Bukhara, Bukhara Region, UzbekistanTakhirov YuldashUrgench State University, 220100 Urgench, UzbekistanRakhmanov KosimSamarkand State Medical University, 140100 Samarkand, UzbekistanAvliyoqulova MusharrafKarshi State University, Kuchabag Street, House-17, Karshi, Qashqadaryo, UzbekistanLola AbduraximovaKimyo International University in Tashkent, Usman Nasyr Street, 156, Tashkent, UzbekistanIsmailova ZukhraWestern Caspian University, Scientific Researcher, Baku, AzerbaijanIbragimkhodjaev BakhodirAlfraganus University, Yukori Karakamish Street 2a, Yunusabad District, Tashkent, UzbekistanKuchkorova Ra'noTashkent State Pedagogical University Named After Nizomi, 100140 Tashkent, UzbekistanAbdullayev DadaxonUrgench State University, 14, Kh. Alimdjan Str, Urganch, Khorezm, UzbekistanDilbar UrazbaevaMamun University, Khiva, Xorazm Region, UzbekistanSullieva SuluvTermez State University, Termez, Surkhondaryo Region, UzbekistanMonireh FarajiDepartment of Chemistry, Islamic Azad University, North Tehran Branch, Tehran, Iran
ABI
Аннотация
investigations revealed enhanced tumor ablation, with the RuSA/NiFe-LDH-MXene + NIR group attaining a tumor inhibition rate of 91.7% without systemic toxicity. This study emphasizes the essential function of LDH coordination in stabilizing Ru single atoms and adjusting their catalytic microenvironment, thereby creating a solid foundation for advanced nanocatalytic cancer treatments.
Темы
Идентификаторы
Цитирования и источники
Цитирований: 0Использованных источников: 66
Показатели — AkademScholar · Скоро